Clinical Trials Supplier Intelligence by key partivipants - IQVIA, PAREXEL International Corporation, Pharmaceutical Product Development
Clinical Trials Procurement Intelligence This clinical trials category is anticipated to grow at a CAGR of 5.8% from 2023 to 2030. North America is the leading region in this category, accounting for over 50.5% of the market share in 2022. This is expected to continue in the forecast period as well, due to several factors, including increased R&D investments and the adoption of new...
0 Commentarii 0 Distribuiri 300 Views 0 previzualizare
Sponsor